文献速递脑血管病外科神经重症

延迟开始的依前列醇输注对蛛网膜下腔出血后内皮功能与损伤标志物的影响

Effect of delayed onset prostacyclin on markers of endothelial function and damage after subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2017-04-07

本研究将90例动脉瘤性蛛网膜下腔出血患者随机分配至依前列醇输注组或安慰剂组,于出血后第5天开始持续低剂量静脉输注至第10天。结果显示,与安慰剂相比,延迟开始的依前列醇输注未影响交感肾上腺激活、内皮激活与损伤及糖萼降解的标志物。作者认为需进一步开展早期开始内皮修复的依前列醇试验。

要点

  • 90例动脉瘤性蛛网膜下腔出血患者随机接受依前列醇或安慰剂。
  • 依前列醇于SAH后第5天开始输注,第10天停止。
  • 延迟开始的依前列醇未影响内皮激活、损伤及糖萼降解标志物。

核心结论

  • 与安慰剂相比,延迟开始的依前列醇输注未发现对交感肾上腺激活、内皮损伤与激活或糖萼降解标志物有任何影响。
  • 作者认为需进一步开展早期开始内皮修复的依前列醇试验。

研究设计与样本

  • 随机对照试验,纳入90例动脉瘤性SAH患者,世界神经外科医师联盟评分1至4分,Fisher分级3或4级,行动脉瘤栓塞或手术夹闭治疗。
  • 患者接受持续低剂量静脉依前列醇输注或安慰剂,于SAH后第5天开始,第10天停止。
  • 在输注前、输注期间及输注后采集血样,用ELISA法测定可溶性内皮细胞激活标志物(sE-选择素、sVE-钙黏蛋白)、损伤标志物(sTM)、糖萼损伤标志物(syndecan-1)及交感肾上腺激活标志物(肾上腺素、去甲肾上腺素)。

主要发现

  • 依前列醇输注未影响交感肾上腺激活标志物。
  • 依前列醇输注未影响内皮激活与损伤标志物。
  • 依前列醇输注未影响内皮糖萼降解标志物。

局限性

  • 作者结论指出需进一步开展早期开始内皮修复的依前列醇试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subarachnoid hemorrhage (SAH) is a neurological emergency. Delayed ischemic neurological deficit is one of the main causes of poor outcome after SAH and is probably caused, at least in part, by cerebral vasospasm. The pathophysiology of this is multifaceted, but endothelial damage and activation as well as glycocalyx damage have been implicated. Prostacyclin has been shown to protect damaged and activated endothelium and to facilitate glycocalyx repair. We investigated biomarkers of endothelial activation and damage in patients with SAH randomized to 5 days prostacyclin infusion or placebo. METHODS: Patients with aneurysmal SAH managed by coiling or surgery, and a World Federation of Neurological Surgeons score between 1 and 4, and Fisher grade 3 or 4, were treated with a continuous low-dose intravenous prostacyclin infusion or placebo initiated on day 5 and discontinued on day 10 after SAH. Blood samples were drawn from the patients before, during and after prostacyclin/placebo infusion. Soluble biomarkers of endothelial cell activation (sE-selectin, sVE-cadherin) and damage (sTM), glycocalyx damage (syndecan-1) and sympathoadrenal activation (adrenaline, noradrenaline), were measured by ELISA. RESULTS: Ninety patients were randomized. Prostacyclin infusion influenced neither biomarkers of sympathoadrenal activation, endothelial activation and damage nor biomarkers of endothelial glycocalyx breakdown. CONCLUSIONS: We did not find any effects on markers of sympathoadrenal activation, endothelial damage and activation, or glycocalyx degradation of delayed onset prostacyclin infusion compared to placebo. Further trials investigating early onset endothelial repair using prostacyclin are warranted.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Gybel-Brask M, Rasmussen R, Stensballe J, et al. Effect of delayed onset prostacyclin on markers of endothelial function and damage after subarachnoid hemorrhage. Acta Neurochir (Wien). 2017. PMID: 28386837. doi:10.1007/s00701-017-3168-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。